Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 259-273

  Lal, Girdhari ^a   Zhang, Nan ^a   Van Der Touw, William ^a   Ding, Yaozhong ^a   Ju, Wenjun ^a   Bottinger, Erwin P ^a   Reid, St Patrick ^b   Levy, David E ^b   Bromberg, Jonathan S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYTOKINE; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; GENOMIC DNA; HISTONE; HISTONE H3; INTERLEUKIN 6; METHYL CPG BINDING PROTEIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR TIEG1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; AZACITIDINE; DRUG DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COLITIS; CYTOLOGY; DRUG EFFECT; FEMALE; GENETIC EPIGENESIS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; AUTOIMMUNE DISEASES; AZACITIDINE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; COLITIS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; T-LYMPHOCYTES, REGULATORY;

EID: 59849085588     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.259     Document Type: Article

References (55)

1. Sakaguchi, S., and F. Powrie. 2007. Emerging challenges in regulatory T cell function and biology. Science 317: 627-629.
2. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169: 5401-5404.
3. Wang, H. Y., and R. F. Wang. 2007. Regulatory T cells and cancer. Curr. Opin. Immunol. 19: 217-223.
4. + regulatory T cells. J. Exp. Med. 201: 1061-1067.
5. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
6. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
7. Kim, H. P., and W. J. Leonard. 2007. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204: 1543-1551.
8. + regulatory T cells. J. Immunol. 178: 280-290.
9. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
10. - precursors. Am. J. Transplant. 4: 1614-1627.
11. + regulatory T cells. Nat. Immunol. 4: 330-336.
12. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8: 277-284.
13. Bluestone, J. A. 2005. Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. 5: 343-349.
14. Ng, H. H., Y. Zhang, B. Hendrich, C. A. Johnson, B. M. Turner, H. Erdjument-Bromage, P. Tempst, D. Reinberg, and A. Bird. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23: 58-61.
15. Feng, Q., and Y. Zhang. 2001. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev. 15: 827-832.
16. Floess, S., J. Freyer, C. Siewert, U. Baron, S. Olek, J. Polansky, K. Schlawe, H. D. Chang, T. Bopp, E. Schmitt, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5: e38.
17. + conventional T cells. Eur. J. Immunol. 37: 2378-2389.
18. Polansky, J. K., K. Kretschmer, J. Freyer, S. Floess, A. Garbe, U. Baron, S. Olek, A. Hamann, H. von Boehmer, and J. Huehn. 2008. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38: 1654-1663.
19. Tone, Y., K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9: 194-202.
20. Lee, G. R., S. T. Kim, C. G. Spilianakis, P. E. Fields, and R. A. Flavell. 2006. T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24: 369-379.
21. Soutto, M., W. Zhou, and T. M. Aune. 2002. Cutting edge: distal regulatory elements are required to achieve selective expression of IFN-γ in Th1/Tc1 effector cells. J. Immunol. 169: 6664-6667.
22. Spilianakis, C. G., and R. A. Flavell. 2004. Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. Nat. Immunol. 5: 1017-1027.
23. Ansel, K. M., D. U. Lee, and A. Rao. 2003. An epigenetic view of helper T cell differentiation. Nat. Immunol. 4: 616-623.
24. Agarwal, S., and A. Rao. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9: 765-775.
25. Fields, P. E., G. R. Lee, S. T. Kim, V. V. Bartsevich, and R. A. Flavell. 2004. Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity 21: 865-876.
26. Yang, X., J. J. Letterio, R. J. Lechleider, L. Chen, R. Hayman, H. Gu, A. B. Roberts, and C. Deng. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18: 1280-1291.
27. Gimeno, R., C. K. Lee, C. Schindler, and D. E. Levy. 2005. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by α/β interferon in T lymphocytes. Mol. Cell. Biol. 25: 5456-5465.
28. Kersh, E. N., D. R. Fitzpatrick, K. Murali-Krishna, J. Shires, S. H. Speck, J. M. Boss, and R. Ahmed. 2006. Rapid demethylation of the IFN-γ gene occurs in memory but not naive CD8 T cells. J. Immunol. 176: 4083-4093.
29. Kantarjian, H. M., S. O'Brien, J. Cortes, F. J. Giles, S. Faderl, J. P. Issa, G. Garcia-Manero, M. B. Rios, J. Shan, M. Andreeff, et al. 2003. Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia. Cancer 98: 522-528.
30. Fujimura, S., T. Matsui, K. Kuwahara, K. Maeda, and N. Sakaguchi. 2008. Germinal center B-cell-associated DNA hypomethylation at transcriptional regions of the AID gene. Mol. Immunol. 45: 1712-1719.
31. Brandeis, M., D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Nemes, V. Temper, A. Razin, and H. Cedar. 1994. Sp1 elements protect a CpG island from de novo methylation. Nature 371: 435-438.
32. Macleod, D., J. Charlton, J. Mullins, and A. P. Bird. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8: 2282-2292.
33. Narlikar, G. J., H. Y. Fan, and R. E. Kingston. 2002. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108: 475-487.
34. Subramaniam, M., J. R. Hawse, S. A. Johnsen, and T. C. Spelsberg. 2007. Role of TIEG1 in biological processes and disease states. J. Cell. Biochem. 102: 539-548.
35. Venuprasad, K., H. Huang, Y. Harada, C. Elly, M. Subramaniam, T. Spelsberg, J. Su, and Y. C. Liu. 2008. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 9: 245-253.
36. Mantel, P. Y., N. Ouaked, B. Ruckert, C. Karagiannidis, R. Welz, K. Blaser, and C. B. Schmidt-Weber. 2006. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176: 3593-3602.
37. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35: 2886-2895.
38. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
39. + Treg development and function during allergic airway inflammation in vivo. J. Clin. Invest. 115: 313-325.
40. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
41. Lyko, F., and R. Brown. 2005. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J. Natl. Cancer Inst. 97: 1498-1506.
42. Egger, G., G. Liang, A. Aparicio, and P. A. Jones. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
43. + T regulatory cells. J. Immunol. 178: 4022-4026.
44. + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
45. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196: 237-246.
46. + regulatory T cells. J. Exp. Med. 201: 737-746.
47. + regulatory T cells. Nat. Immunol. 9: 632-640.
48. Tao, R., E. F. de Zoeten, E. Ozkaynak, C. Chen, L. Wang, P. M. Porrett, B. Li, L. A. Turka, E. N. Olson, M. I. Greene, et al. 2007. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13: 1299-1307.
49. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.
50. + regulatory T cells. Proc. Natl. Acad. Sci. USA 104: 18169-18174.
51. Mantel, P. Y., H. Kuipers, O. Boyman, C. Rhyner, N. Ouaked, B. Ruckert, C. Karagiannidis, B. N. Lambrecht, R. W. Hendriks, R. Crameri, et al. 2007. GATA3-driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 5: e329.
52. Zhang, Q., H. Y. Wang, A. Woetmann, P. N. Raghunath, N. Odum, and M. A. Wasik. 2006. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood 108: 1058-1064.
53. Zhang, Q., H. Y. Wang, M. Marzec, P. N. Raghunath, T. Nagasawa, and M. A. Wasik. 2005. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc. Natl. Acad. Sci. USA 102: 6948-6953.
54. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354.
55. + T-cell activation. Immunology 119: 203-211.